PLx Pharma Inc. (PLXP) Financials

NASDAQ Currency in USD Disclaimer

$0.09

north_east NA Past Year
Day's range
$0.08
Day's range
$0.16
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40M-$50M-$50M-$60M-$60MEarning2015201520162016201720172018201820192019202020202021202120000%20000%10000%10000%0%0%-10000%-10000%-20000%-20000%-30000%-30000%-40000%-40000%-50000%-50000%Profit Margin
Profit Margin
Revenue
Earnings

PLXP Income statement / Annual

Last year (2021), PLx Pharma Inc.'s total revenue was $8.21 M, an increase of 26,873.38% from the previous year. In 2021, PLx Pharma Inc.'s net income was -$51.46 M. See PLx Pharma Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Operating Revenue $8.21 M $30,430.00 $565,464.00 $753,108.00 $778,657.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $4.81 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $3.40 M $30,430.00 $565,464.00 $753,108.00 $778,657.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.41 1 1 1 1 0 0 0 0 0
Research and Development Expenses $4.18 M $4.34 M $4.74 M $3.92 M $4.16 M $12.75 M $11.29 M $8.90 M $1.73 M $844,630.00
General & Administrative Expenses $0.00 $9.15 M $10.03 M $7.79 M $10.17 M $8.61 M $7.48 M $4.68 M $2.28 M $999,356.00
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $40.01 M $9.15 M $10.03 M $7.79 M $10.17 M $8.61 M $7.48 M $4.68 M $2.28 M $999,356.00
Other Expenses $0.00 $0.00 $0.00 $0.00 $2.29 M $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $44.19 M $13.49 M $14.77 M $11.71 M $14.33 M $21.37 M $18.76 M $13.58 M $4.01 M $1.84 M
Cost And Expenses $49.00 M $13.49 M $14.77 M $11.71 M $14.33 M $21.37 M $18.76 M $13.58 M $4.01 M $1.84 M
Interest Income $0.00 $0.00 $405,239.00 $297,800.00 $112,377.00 $46,769.00 $22,057.00 $0.00 $0.00 $0.00
Interest Expense $1,000.00 $307,950.00 $994,979.00 $1.15 M $1.16 M $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $5.55 M $415,614.00 $405,239.00 $200,957.00 $746,008.00 $46,769.00 $22,057.00 $0.00 $0.00 $0.00
EBITDA -$35.24 M -$13.46 M -$13.80 M $2.24 M -$15.10 M -$21.32 M -$18.74 M -$13.58 M -$4.01 M -$1.84 M
EBITDA Ratio -4.29 -442.3 -24.4 2.98 -19.39 0 0 0 0 0
Operating Income Ratio -4.97 -442.3 -25.12 -14.55 -20.35 0 0 0 0 0
Total Other Income/Expenses Net -$5.34 M -$1.75 M -$6.30 M $11.86 M -$418,889.00 $46,769.00 $22,057.00 $0.00 $0.00 $0.00
Income Before Tax -$46.13 M -$15.21 M -$20.50 M $896,480.00 -$16.27 M -$21.32 M -$18.74 M -$13.58 M -$4.01 M -$1.84 M
Income Before Tax Ratio -5.62 -499.86 -36.26 1.19 -20.89 0 0 0 0 0
Income Tax Expense $5.34 M -$107,664.00 $836,726.00 $13.00 M -$920,000.00 $0.00 $0.00 $0.00 $0.00 $0.00
Net Income -$51.46 M -$15.10 M -$21.34 M $896,480.00 -$15.35 M -$21.32 M -$18.74 M -$13.58 M -$4.01 M -$1.84 M
Net Income Ratio -6.27 -496.32 -37.74 1.19 -19.71 0 0 0 0 0
EPS -2.18 -1.55 -2.39 0.1 -2.19 -16.45 -15.9 -13.84 -6.94 -3.64
EPS Diluted -2.18 -1.55 -2.39 0.1 -2.19 -16.45 -15.9 -13.84 -6.94 -3.64
Weighted Average Shares Out $23.65 M $9.71 M $8.92 M $8.73 M $7.02 M $1.30 M $1.18 M $981,293.00 $577,982.00 $507,035.00
Weighted Average Shares Out Diluted $23.65 M $9.71 M $8.92 M $8.73 M $7.02 M $1.30 M $1.18 M $981,293.00 $577,982.00 $507,035.00
Link